Drug details

Xtampza ER (oxycodone extended-release capsules)

type of Opioid Analgesics

Xtampza ER (oxycodone) extended-release is an opioid agonist product indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

This drug may have the following side effects:

• nausea,
• vomiting,
• diarrhea,
• lightheadedness,
• shortness of breath,
• weight loss,
• tiredness,
• low blood pressure,
• fainting,
• abdominal pain,
• depression,
• daytime sleepiness,
• blurred vision, and
• unusual thirst,
• lack of concentration,
• decreased appetite,
• dehydration,
• extreme fatigue,
• salt craving,
• low blood sugar,
• slow and shallow breathing,
• darkening of your skin,
• sedation

The following drugs are related to Xtampza ER, either as a replacement or used together:

• Stadol (butorphanol tartrate)
• Demerol (meperidine)
• Dilaudid (hydromorphone hydrochloride)
• Dilaudid-HP (hydromorphone hydrochloride injection)
• Norco (hydrocodone bitartrate and acetaminophen)
• Norco 5/325 (hydrocodone bitartrate and acetaminophen)
• Zamicet (hydrocodone bitartrate and acetaminophen oral solution)
• Percocet (oxycodone and acetaminophen)
• Oxycontin (oxycodone hcl)
• Ultram (tramadol hcl)
• Ultram ER (tramadol hcl extended-release)
• Ultracet (tramadol hydrochloride and acetaminophen tablets)